Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.

Détails

Ressource 1Télécharger: 32585161_pp_cover.pdf (15420.36 [Ko])
Etat: Public
Version: Author's accepted manuscript
Licence: Non spécifiée
ID Serval
serval:BIB_B2C6A0D6E007
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Périodique
Journal of hepatology
Auteur(s)
Fraga M., Moradpour D., Artru F., Romailler E., Tschopp J., Schneider A., Chtioui H., Neerman-Arbez M., Casini A., Alberio L., Sempoux C.
ISSN
1600-0641 (Electronic)
ISSN-L
0168-8278
Statut éditorial
Publié
Date de publication
10/2020
Peer-reviewed
Oui
Volume
73
Numéro
4
Pages
967-970
Langue
anglais
Notes
Publication types: Case Reports ; Letter
Publication Status: ppublish
Mots-clé
Betacoronavirus/isolation & purification, COVID-19, Coronavirus Infections/diagnosis, Coronavirus Infections/physiopathology, Diagnosis, Differential, Fibrinogen/analysis, Glycogen Storage Disease Type IV/diagnosis, Hepatitis/etiology, Hepatitis/pathology, Hepatitis/physiopathology, Hepatitis B, Chronic/diagnosis, Humans, Inclusion Bodies/pathology, Lafora Disease/diagnosis, Liver/diagnostic imaging, Liver/pathology, Liver Function Tests/methods, Male, Middle Aged, Pandemics, Patient Care Management/methods, Pneumonia, Ventilator-Associated/therapy, Pneumonia, Viral/diagnosis, Pneumonia, Viral/physiopathology, Pulmonary Embolism/diagnosis, Pulmonary Embolism/etiology, Pulmonary Embolism/physiopathology, Respiration, Artificial/adverse effects, Respiration, Artificial/methods, SARS-CoV-2, Treatment Outcome
Pubmed
Web of science
Open Access
Oui
Création de la notice
26/06/2020 13:48
Dernière modification de la notice
23/12/2020 7:24
Données d'usage